Pike Therapeutics specializes in developing safe and effective cannabinoid formulations with superior drug delivery.
Pike Therapeutics has raised $760K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2026.
Pike Therapeutics is headquartered in Toronto, Canada.
Pike Therapeutics specializes in developing safe and effective cannabinoid formulations with superior drug delivery.
Pike Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pike Therapeutics — Funding & Investors." VCBacked, July 17, 2026, https://www.vcbacked.co/company/pike-therapeutics. Accessed November 6, 2026.
VCBacked. (2026). Pike Therapeutics — Funding & Investors. Retrieved November 6, 2026, from https://www.vcbacked.co/company/pike-therapeutics
{{cite web |title=Pike Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/pike-therapeutics |website=VCBacked |access-date=November 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Pike Therapeutics? Request a listing update